1. British Society for Immunology. Immunodeficiency. Available at: https://www.immunology.org/policy-and-public-affairs/briefings-and-position-statements/immunodeficiency. Accessed: 20 March 2025.

2. Li PH, et al. Secondary antibody deficiency and immunoglobulin replacement. Hong Kong Bulletin on Rheumatic Diseases 2017;17(1):1-5.

3. Health Quality Ontario. Home-Based Subcutaneous Infusion of Immunoglobulin for Primary and Secondary Immunodeficiencies: A Health Technology Assessment. Ont Health Technol Assess Ser 2017;17(16):1-86.

4. Ballow M. Practical aspects of immunoglobulin replacement. Ann Allergy Asthma Immunol. 2017;119(4):299-303

5. Albin S, et al. An update on the use of immunoglobulin for the treatment of immunodeficiency disorders. Immunotherapy 2014;6(10):1113-1126.

6. Ponsford M, et al. Facilitated subcutaneous immunoglobulin (fSCIg) therapy–practical considerations. Clin Exp Immunol. 2015 Dec;182(3):302-13.